Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.19.3.a.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Dec. 31, 2019
Mar. 31, 2019
Current assets    
Cash $ 4,058,653 $ 3,828,074
Accounts receivable 206,729 0
Prepaid expenses and other current assets 40,351 210,042
Total current assets 4,305,733 4,038,116
Property and equipment, net 144,966 6,021
Right-of-use lease asset 159,838 0
Patents, net 59,795 66,668
Deposits 12,159 12,159
Total assets 4,682,491 4,122,964
Current liabilities    
Accounts payable 327,408 131,931
Due to related parties 111,212 83,654
Convertible notes payable, net 0 962,301
Deferred revenue 100,000 0
Lease liability, current portion 96,712 0
Other current liabilities 175,282 646,000
Total current liabilities 810,614 1,823,886
Lease liability, less current portion 67,695 0
Total liabilities 878,309 1,823,886
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 4,779,614 and 1,266,979 shares issued and outstanding as of December 31, 2019 and March 31, 2019, respectively 4,781 1,267
Additional paid-in capital 114,172,714 108,076,275
Accumulated deficit (110,243,475) (105,652,433)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 3,934,020 2,425,109
Noncontrolling interests (129,838) (126,031)
Total stockholders' equity 3,804,182 2,299,078
Total liabilities and stockholders' equity $ 4,682,491 $ 4,122,964